Clinical trial
Determining Optimal Continuation Treatment Duration for Depressed Children and…
NCT00332787 · University of Texas Southwestern Medical Center, Other · Completed
Key facts
| NCT number | NCT00332787 |
|---|---|
| Title | Determining Optimal Continuation Treatment Duration for Depressed Children and Adolescents |
| Official title | Childhood Depression: Remission and Relapse |
| Lead sponsor | University of Texas Southwestern Medical Center, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Depression |
| Intervention type | Drug |
| Interventions | Fluoxetine |
| Enrollment | 200 |
| Start date | Jun 1, 2000 |
| Completion | Oct 1, 2005 |
| First posted | Jun 2, 2006 |
| Last update posted | Jan 8, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: